Lv3
334 积分 2023-11-10 加入
Crisugabalin, a ligand for the αδ subunit of voltage-gated calcium channels, exhibits no obvious abuse potential in rodents
2天前
已完结
Crisugabalin, a ligand for the αδ subunit of voltage-gated calcium channels, exhibits no obvious abuse potential in rodents
2天前
已完结
Treatment Patterns and Outcomes in Patients with Multiple Myeloma Who Received Ixazomib and in Patients with Triple-Class Refractory Multiple Myeloma: A Retrospective, Observational, Real-World Historical Database Analysis Study from China
5天前
已关闭
An immunostimulatory CELMoD combination overcomes resistance to T-cell engagers caused by a high multiple myeloma burden
5天前
已完结
Evidence-based mechanisms of synergy with IMiD agent-based combinations in multiple myeloma
5天前
已完结
Mezigdomide (CC-92480), a Potent, Novel Cereblon E3 Ligase Modulator (CELMoD), Combined with Dexamethasone (DEX) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results from the Dose-Expansion Phase of the CC-92480-MM-001 Trial
6天前
已关闭
First-line Therapy in Newly Diagnosed Multiple Myeloma
10天前
已完结
Treatment Decisions in Multiple Myeloma
11天前
已完结
Immunomodulatory drugs: a promising clinical ally for cancer immunotherapy
17天前
已完结
Drugging the undruggable: Chemical and biological insights into molecular glues in the pipeline
17天前
已完结
皖公网安备34019202002308
